IL33 and gastric cancer: High expression of ILC2 has been detected in solid tumors such as breast, lung, prostate, and gastric cancer, as the IL-33 produced by them is the main activator of ILC2 and usually promotes tumor growth, angiogenesis, and metastasis [14] [38] [5].